Concurrent Investment Advisors, LLC Acadia Pharmaceuticals Inc Transaction History
Concurrent Investment Advisors, LLC
- $4.12 Trillion
- Q1 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 14,881 shares of ACAD stock, worth $217,262. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,881Holding current value
$217,262% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
334Shares Held
167MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$626 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$176 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$127 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.36B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...